Edition:
United Kingdom

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

1.72USD
12 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.72
Open
$1.84
Day's High
$1.87
Day's Low
$1.72
Volume
154,982
Avg. Vol
85,572
52-wk High
$15.27
52-wk Low
$1.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.745
Jun '18 0.00 -0.647
Mar '18 0.00 -0.619
FY 2017 Dec '17 0.05 -0.651
Sep '17 0.16 -0.724
Jun '17 0.13 -0.544
Mar '17 0.00 -0.411
FY 2016 Dec '16 0.00 -0.246
Sep '16 0.00 -0.274
Jun '16 0.00 -0.248
Mar '16 0.50 -0.278
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 8 0.00 0.00 0.00 0.00
Year Ending Dec-19 8 2.11 10.90 0.00 7.44
Earnings (per share)
Quarter Ending Dec-18 8 -0.57 -0.31 -0.76 -0.64
Quarter Ending Mar-19 4 -0.35 -0.29 -0.42 -0.66
Year Ending Dec-18 7 -2.50 -2.04 -2.77 -2.32
Year Ending Dec-19 8 -1.43 -1.04 -1.85 -2.14
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 81.01 29.57
P/E High - Last 5 Yrs. -- 267.91 46.44
P/E Low - Last 5 Yrs. -- 85.11 24.51
Beta -- 0.74 0.88
Price to Sales (TTM) 1,071.36 232.78 15.43
Price to Book (MRQ) 1.34 16.33 4.06
Price to Tangible Book (MRQ) 1.34 20.88 13.80
Price to Cash Flow (TTM) -- 48.95 21.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.40 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.45
Dividend 5 Year Growth Rate -- 3.72 -5.78
Payout Ratio(TTM) -- 7.81 41.88

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 148.87 7.10
Sales (TTM) vs TTM 1 Yr. Ago -81.36 63.88 5.63
Sales - 5 Yr. Growth Rate -- 22.16 7.39
EPS (MRQ) vs Qtr. 1 Yr. Ago -3.01 46.11 36.31
EPS (TTM) vs TTM 1 Yr. Ago -38.38 -- --
EPS - 5 Yr. Growth Rate -- 20.32 7.73
Capital Spending - 5 Yr. Growth Rate -- 34.35 8.00

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.36 2.55
Current Ratio (MRQ) 4.59 6.59 3.51
LT Debt to Equity (MRQ) 22.48 18.51 11.13
Total Debt to Equity (MRQ) 22.48 23.97 14.84
Interest Coverage (TTM) -- -205.37 40.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.29 54.38
Gross Margin - 5 Yr. Avg. -- 47.38 52.96
EBITD Margin (TTM) -140,810.91 -- --
EBITD - 5 Yr. Avg -- -162.73 15.85
Operating Margin (TTM) -141,152.70 -1,819.18 -16.28
Operating Margin - 5 Yr. Avg. -- -175.96 11.08
Pre-Tax Margin (TTM) -141,223.59 -1,749.43 -14.67
Pre-Tax Margin - 5 Yr. Avg. -- -178.84 11.39
Net Profit Margin (TTM) -141,223.59 -1,744.55 -18.01
Net Profit Margin - 5 Yr. Avg. -- -178.80 7.65
Effective Tax Rate (TTM) -- 14.32 21.32
Effective Tax Rate - 5 Yr. Avg. -- 18.97 24.45

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,618 24,520,427 722,980,797
Net Income/Employee (TTM) -2,284,500 -3,918,019 83,628,555
Receivable Turnover (TTM) -- 8.33 5.19
Inventory Turnover (TTM) -- 2.80 4.12
Asset Turnover (TTM) 0.00 0.47 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -125.02 -0.91 10.15
Return on Assets - 5 Yr. Avg. -- 2.43 10.82
Return on Investment (TTM) -159.01 -0.53 12.77
Return on Investment - 5 Yr. Avg. -- 2.24 13.88
Return on Equity (TTM) -191.84 -3.22 14.47
Return on Equity - 5 Yr. Avg. -- -1.62 15.19
  1 Year 3 Year 5 Year
Sales % -33.65 -- --
EPS (TTM) % -127.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clearside Biomedical Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -65.67 -65.84 1 92
13 Week -75.76 -75.30 2 95
26 Week -84.21 -84.51 2 94
52 Week -74.93 -76.70 9 98
YTD -73.71 -74.73 8 93
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.90%
# of Holders: 118
Total Shares Held: 24,307,473
3 Mo. Net Change: 575,561
# New Positions: 9
# Closed Positions: 7
# Increased Positions: 26
# Reduced Positions: 14
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.